Cardiac 123I-mIBG scintigraphy for prediction of catheter ablation outcome in patients with atrial fibrillation

被引:2
|
作者
Sazonova, S. I. [1 ]
Varlamova, J. V. [1 ]
Nikitin, N. A. [2 ]
Minin, S. M. [2 ]
Kisteneva, I. V. [1 ]
Batalov, R. E. [1 ]
Mishkina, A. I. [1 ]
Ilushenkova, Y. N. [1 ]
Zavadovsky, K. V. [1 ]
Popov, S. V. [1 ]
Romanov, A. B. [2 ]
机构
[1] Russian Acad Sci, Cardiol Res Inst, Tomsk NRMC, Cardiol Res Inst,Tomsk Natl Res Med Ctr, Tomsk, Russia
[2] Minist Hlth Russian Federat, E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia
基金
俄罗斯科学基金会;
关键词
atrial fibrillation; catheter ablation; cardiac innervation; scintigraphy; I-123-mIBG; prognosis; AUTONOMIC NERVOUS-SYSTEM; SPECT; ARRHYTHMIAS;
D O I
10.1007/s12350-021-02658-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies show inconsistent results on the role of innervation imaging (with I-123-mIBG) in predicting late atrial fibrillation (AF) recurrence after catheter ablation (CA). These studies included patients with paroxysmal AF and studied prognostic value of post-CA I-123-mIBG parameters. Current study investigated the ability of pre CA 123-I-mIBG imaging to predict late AF recurrence in patients with persistent AF. Methods I-123-mIBG cardiac imaging was performed before CA in 82 patients with persistent AF. Patient was followed for 12 months. Results Multivariable analysis demonstrated that late heart-to-mediastinum ratio (H/M-late) and washout rate (WR) were independent predictors of AF recurrence. ROC-curve analysis data showed that H/M-late <1.6 (sensitivity 73.53%, specificity 81.3%, AUC 0.792, P < .001) and WR > 25.11 (sensitivity 70.6%, specificity 70.8.3%, AUC 0.712, P < .001) indicate high probability of AF relapses during 12 months after CA. Conclusion Pre-CA parameters of global cardiac sympathetic activity estimated by I-123-mIBG scintigraphy are associated with late AF relapses in persistent AF patients with normal LVEF and absence of significant CAD.
引用
收藏
页码:2220 / 2231
页数:12
相关论文
共 50 条
  • [41] 123I-MetaIodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movement disorders
    Nuvoli, S.
    Piras, M. R.
    Nieddu, A.
    Dachena, G.
    Spanu, A.
    Madeddu, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S348 - S348
  • [42] Doubtful parkinsonian syndromes (dPS): Usefulness of 123I-metaiodobenzylguanidine (123I-MIBG) cardiac scintigraphy
    Nuvoli, Susanna
    Piras, Maria
    Nieddu, Antonio
    Chessa, Francesca
    Spanu, Angela
    Madeddu, Giuseppe
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [43] Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders
    Escamilla-Sevilla, F.
    Perez-Navarro, M. J.
    Munoz-Pasadas, M.
    Ortega-Leon, T.
    Gallego-Peinado, M.
    Cabello-Garcia, D.
    Gomez-Rio, M.
    Ortega-Moreno, A.
    Carnero-Pardo, C.
    Rebollo-Aguirre, A. C.
    Minguez-Castellanos, A.
    NEUROLOGIA, 2009, 24 (03): : 170 - 176
  • [44] Early diagnosis of cardiac involvement in systemic sclerosis by 123I-MIBG neurotransmitter scintigraphy
    Gurtner, C
    Werner, RJ
    Winten, G
    Krause, BJ
    Wendt, T
    Hor, G
    Holzmann, H
    NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (09) : 849 - 857
  • [45] 123I-MIBG cardiac scintigraphy in differentiating movement disorders by a Random Forest classifier
    Nuvoli, Susanna
    Palumbo, Barbara
    Fravolini, Mario
    Buresta, Tommaso
    Spanu, Angela
    Madeddu, Giuseppe
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [46] Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder
    Miyamoto, T.
    Miyamoto, M.
    Inoue, Y.
    Usui, Y.
    Suzuki, K.
    Hirata, K.
    NEUROLOGY, 2006, 67 (12) : 2236 - 2238
  • [47] 123I-MIBG cardiac scintigraphy in differentiating movement disorders by a Random Forest classifier
    Nuvoli, Susanna
    Palumbo, Barbara
    Fravolini, Mario
    Buresta, Tommaso
    Spanu, Angela
    Madeddu, Giuseppe
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [48] Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD
    Saiki, S
    Hirose, G
    Sakai, K
    Kataoka, S
    Hori, A
    Saiki, M
    Kaito, M
    Higashi, K
    Taki, S
    Kakeshita, K
    Fujino, S
    Miaki, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 220 (1-2) : 105 - 111
  • [49] 123I-MIBG myocardial scintigraphy in patients with left ventricular apical ballooning
    Akashi, Y.
    Koh, S.
    Kida, K.
    Yoneyama, K.
    Sasaka, K.
    Imanishi, K.
    Miyake, F.
    EUROPEAN HEART JOURNAL, 2008, 29 : 887 - 887
  • [50] Potential Role of 123I-mIBG Scintigraphy in Takotsubo Cardiomyopathy
    Currie, Geoffrey
    Iqbal, Basit
    Kiat, Hosen
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57